sVCAM-1 levels were correlated with activated B-cell subsets including CD95+CD27+ memory B cells and CD95+ plasmablasts, consistent with the importance of these B-cell subsets in aberrant plasma cell development in SLE [29]. The gene discussed is CD27; the disease is systemic lupus erythematosus.